3-(ARYL OR HETEROARYL) METHYLENEINDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF CANCER STEM CELL PATHWAY KINASES FOR THE TREATMENT OF CANCER
The invention provides compounds of Formula I as inhibitors of cancer stem cells as well as cancer stem cell pathway kinase and other related kinases, pharmaceutical compositions and uses thereof in the treatment of cancer or a related disorder in a mammal, wherein i.a. R2 is an optionally substitut...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
31.05.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!